She, Q.-B., et al.. Resistance to Gefitinib in Pten-null Her-overexpressing Tumor Cells Can Be Overcome Through Restoration of PTEN Function or Pharmacologic Modulation of Constitutive Phosphatidylinositol 3'-kinase/akt Pathway Signaling. no. 12, Oct. 2003.